Table 1.

Key differences between GETUG-AFU 15 and ECOG 3805 studies

	GETUG	ECOG
Total sample size	385	790
High-volume disease	183 (47.5%)	514 (65%)
Median follow-up	83 months	29 months
Received post-protocol docetaxel	ADT-only arm: 80% ADT-docetaxel arm: 45%	ADT-only arm: 33% ADT-docetaxel arm: 12%
Received post-protocol abiraterone or enzalutamide	ADT-only arm: No response ADT-docetaxel arm: No response	ADT-only arm: 20% DT-docetaxel arm: 23%

GETUG-AFU: Groupe d’Etude des Tumeurs Uro-Genital-Association Française d’Urologie; ECOG: Eastern Cooperative Oncology Group; ADT: androgen deprivation therapy.